muscle e relaxant肌弛缓药
muscle-relaxant efficacy index肌肉松弛效果指数
peripheral muscle relaxant末梢性肌弛缓剂
central muscle relaxant中枢性肌松弛药
Nondepolarizing muscle relaxant非去极化肌松药;释义非去极化肌松剂
a muscle relaxant肉毒杆菌
herbaceous muscle relaxant中草药肌松剂
dual muscle relaxant双相类肌松药
centrally muscle relaxant中枢性肌肉弛缓剂
Conclusion:Induction of anesthesia with TCI of propofol at target effect site concentration of 4 μg/ml and surface anesthesia might provide satisfactory intubating conditions without muscle relaxant.
结论：无肌松药下用2%利多卡因4～5 ml行气管黏膜表面麻醉复合异丙酚4 μg/ml效应室浓度靶控输注诱导病人气管插管时，可提供良好的气管插管条件。
Purpose To improve the reliability of monitoring by the range of suitable muscle relaxant’s concentration under the condition of successful motor evoked potential monitoring.
目的确定适合运动诱发电位(MEP)术中监测的肌松剂浓度范围,以提高监护可靠性和手术安全性。
参考来源 - 全麻下术中运动神经监护与肌松剂浓度的协调性研究